<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">34858230</PMID><DateRevised><Year>2021</Year><Month>12</Month><Day>04</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">1664-0640</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><PubDate><Year>2021</Year></PubDate></JournalIssue><Title>Frontiers in psychiatry</Title><ISOAbbreviation>Front Psychiatry</ISOAbbreviation></Journal><ArticleTitle>Do Anxiety and Depression Predict Persistent Physical Symptoms After a Severe COVID-19 Episode? A Prospective Study.</ArticleTitle><Pagination><StartPage>757685</StartPage><MedlinePgn>757685</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">757685</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fpsyt.2021.757685</ELocationID><Abstract><AbstractText><b>Background:</b> Persistent physical symptoms are common after a coronavirus disease 2019 (COVID-19) episode, but their pathophysiological mechanisms remain poorly understood. In this study, we aimed to explore the association between anxiety and depression at 1-month after acute infection and the presence of fatigue, dyspnea, and pain complaints at 3-month follow-up. <b>Methods:</b> We conducted a prospective study in patients previously hospitalized for COVID-19 followed up for 3 months. The Hospital Anxiety and Depression Scale (HAD-S) was administered by physicians at 1-month follow-up, and the presence of fatigue, dyspnea, and pain complaints was assessed at both 1 month and 3 months. Multivariable logistic regressions explored the association between anxiety and depression subscores and the persistence of each of the physical symptom at 3 months. <b>Results:</b> A total of 84 patients were included in this study (Median age: 60 years, interquartile range: 50.5-67.5 years, 23 women). We did not find any significant interaction between anxiety and the presence of fatigue, dyspnea, or pain complaints at 1 month in predicting the persistence of these symptoms at 3 months (all <i>p</i> &#x2265; 0.36). In contrast, depression significantly interacted with the presence of pain at 1 month in predicting the persistence of pain at 3 months (OR: 1.60, 95% CI: 1.02-2.51, <i>p</i> = 0.039), with a similar trend for dyspnea (OR: 1.51, 95% CI: 0.99-2.28, <i>p</i> = 0.052). <b>Discussion and Conclusion:</b> Contrary to anxiety, depression after an acute COVID-19 episode may be associated with and increased risk of some persistent physical symptoms, including pain and dyspnea.</AbstractText><CopyrightInformation>Copyright &#xa9; 2021 Bottemanne, Gouraud, Hulot, Blanchard, Ranque, Lahlou-Lafor&#xea;t, Limosin, G&#xfc;nther, Lebeaux and Lemogne.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Bottemanne</LastName><ForeName>Hugo</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Paris Brain Institute - Institut du Cerveau et de la Moelle &#xc9;pini&#xe9;re, UMR 7225, UMR_S 1127, CNRS, INSERM, Sorbonne University, Service de Psychiatrie de l'Adulte, H&#xf4;pital de la Piti&#xe9;-Salp&#xea;tri&#xe9;re, DMU Neurosciences, Assistance Publique-H&#xf4;pitaux De Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gouraud</LastName><ForeName>Cl&#xe9;ment</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de Psychiatrie de l'Adulte, DMU Psychiatrie et Addictologie, H&#xf4;pital H&#xf4;tel-Dieu, Universit&#xe9; de Paris, Assistance Publique-Hopitaux de Paris, Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hulot</LastName><ForeName>Jean-S&#xe9;bastien</ForeName><Initials>JS</Initials><AffiliationInfo><Affiliation>CIC 1418 and DMU CARTE, Assistance Publique Hopitaux De Paris, H&#xf4;pital Europ&#xe9;en Georges-Pompidou, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blanchard</LastName><ForeName>Anne</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Service de N&#xe9;phrologie, Assistance Publique Hopitaux De Paris, H&#xf4;pital Europ&#xe9;en-Georges Pompidou, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ranque</LastName><ForeName>Brigitte</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Service de M&#xe9;decine Interne, Assistance Publique Hopitaux De Paris, H&#xf4;pital Europ&#xe9;en-Georges Pompidou, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lahlou-Lafor&#xea;t</LastName><ForeName>Khadija</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>DMU Psychiatrie et Addictologie, Service de Psychiatrie de l'Adulte, Assistance Publique Hopitaux De Paris, H&#xf4;pital Europ&#xe9;en-Georges Pompidou, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Limosin</LastName><ForeName>Fr&#xe9;d&#xe9;ric</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>DMU Psychiatrie et Addictologie, Service de Psychiatrie de l'Adulte, Assistance Publique Hopitaux De Paris, H&#xf4;pital Corentin Celton, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>G&#xfc;nther</LastName><ForeName>Sven</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Innovative Therapies in Haemostasis, INSERM, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Physiologie, Assistance Publique Hopitaux De Paris, Georges Pompidou European Hospital, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lebeaux</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Service de Microbiologie, Unit&#xe9; Mobile d'Infectiologie, Assistance Publique Hopitaux De Paris, H&#xf4;pital Europ&#xe9;en Georges Pompidou, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lemogne</LastName><ForeName>C&#xe9;dric</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Service de Microbiologie, Unit&#xe9; Mobile d'Infectiologie, Assistance Publique Hopitaux De Paris, H&#xf4;pital Europ&#xe9;en Georges Pompidou, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Service de Psychiatrie de l'Adulte, H&#xf4;pital H&#xf4;tel-Dieu, DMU Psychiatrie et Addictologie, Assistance Publique Hopitaux De Paris, INSERM, Institut de Psychiatrie et Neurosciences de Paris, UMR_S1266, Universit&#xe9; de Paris, Paris, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Psychiatry</MedlineTA><NlmUniqueID>101545006</NlmUniqueID><ISSNLinking>1664-0640</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">anxiety</Keyword><Keyword MajorTopicYN="N">depression</Keyword><Keyword MajorTopicYN="N">fatigue pain</Keyword><Keyword MajorTopicYN="N">long Covid</Keyword><Keyword MajorTopicYN="N">post-acute COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">post-covid condition</Keyword><Keyword MajorTopicYN="N">somatoform disorders</Keyword></KeywordList><CoiStatement>CL reports personal fees and non-financial support from Janssen-Cilag, Lundbeck, Otsuka Pharmaceutical, and Boehringer Ingelheim in the previous 3 years, outside the submitted work. The APHP, which employs J-SH, has received research grants from Bioserenity, Sanofi, Servier, and Novo Nordisk. J-SH has received speaker, advisory board or consultancy fees from Amgen, Astra Zeneca, Bayer, Bristol-Myers Squibb, Novartis, WeHealth. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>8</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>12</Month><Day>3</Day><Hour>7</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>12</Month><Day>4</Day><Hour>6</Hour><Minute>1</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2021</Year><Month>11</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34858230</ArticleId><ArticleId IdType="pmc">PMC8631493</ArticleId><ArticleId IdType="doi">10.3389/fpsyt.2021.757685</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Moreno C, Wykes T, Galderisi S, Nordentoft M, Crossley N, Jones N, et al. . How mental health care should change as a consequence of the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:813&#x2013;24. 10.1016/S2215-0366(20)30307-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30307-2</ArticleId><ArticleId IdType="pmc">PMC7365642</ArticleId><ArticleId IdType="pubmed">32682460</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizumoto K, Chowell G. Estimating risk for death from coronavirus disease, China, January&#x2013;February 2020. Emerg Infect Dis. (2020) 26:1251&#x2013;6. 10.3201/eid2606.200233</Citation><ArticleIdList><ArticleId IdType="doi">10.3201/eid2606.200233</ArticleId><ArticleId IdType="pmc">PMC7258458</ArticleId><ArticleId IdType="pubmed">32168464</ArticleId></ArticleIdList></Reference><Reference><Citation>Cort&#xe9;s-Telles A, L&#xf3;pez-Romero S, Figueroa-Hurtado E, Pou-Aguilar YN, Wong AW, Milne KM, et al. . Pulmonary function and functional capacity in COVID-19 survivors with persistent dyspnoea. Respir Physiol Neurobiol. (2021) 288:103644. 10.1016/j.resp.2021.103644</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.resp.2021.103644</ArticleId><ArticleId IdType="pmc">PMC7910142</ArticleId><ArticleId IdType="pubmed">33647535</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudroff T, Fietsam AC, Deters JR, Bryant AD, Kamholz J. Post-COVID-19 fatigue: potential contributing factors. Brain Sci. (2020). 10:1012. 10.3390/brainsci10121012</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/brainsci10121012</ArticleId><ArticleId IdType="pmc">PMC7766297</ArticleId><ArticleId IdType="pubmed">33352638</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, et al. . &#x201c;Long-COVID&#x201d;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. (2020) 76(4):396&#x2013;8. 10.1136/thoraxjnl-2020-215818</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Cares-Marambio K, Montenegro-Jim&#xe9;nez Y, Torres-Castro R, Vera-Uribe R, Torralba Y, Alsina-Restoy X, et al. . Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019(COVID-19): a systematic review and meta-analysis. Chron Respir Dis. (2021) 18:14799731211002240. 10.1177/14799731211002240</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/14799731211002240</ArticleId><ArticleId IdType="pmc">PMC7975482</ArticleId><ArticleId IdType="pubmed">33729021</ArticleId></ArticleIdList></Reference><Reference><Citation>Matta J, Wiernik E, Robineau O, Carrat F, Touvier F, Severi G. Association of self-reported COVID-19 and SARS-CoV-2 serology results with persistent physical symptoms among French adults during the COVID-19 pandemic. JAMA Int Med. (2021).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8576624</ArticleId><ArticleId IdType="pubmed">34747982</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. . Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. (2021) 594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Troyer EA, Kohn JN, Hong S. Are we facing a crashing wave of neuropsychiatric sequelae of COVID-19? Neuropsychiatric symptoms and potential immunologic mechanisms. Brain Behav Immun. (2020) 87:34&#x2013;9. 10.1016/j.bbi.2020.04.027</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.04.027</ArticleId><ArticleId IdType="pmc">PMC7152874</ArticleId><ArticleId IdType="pubmed">32298803</ArticleId></ArticleIdList></Reference><Reference><Citation>Zunszain PA, Anacker C, Cattaneo A, Carvalho LA, Pariante CM. Glucocorticoids, cytokines and brain abnormalities in depression. Prog Neuropsychopharmacol Biol Psychiatry. (2011) 35:722&#x2013;9. 10.1016/j.pnpbp.2010.04.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pnpbp.2010.04.011</ArticleId><ArticleId IdType="pmc">PMC3513408</ArticleId><ArticleId IdType="pubmed">20406665</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaracz J, Gattner K, Jaracz K, G&#xf3;rna K. Unexplained painful physical symptoms in patients with major depressive disorder: prevalence, pathophysiology and management. CNS Drugs. (2016) 30:293&#x2013;304. 10.1007/s40263-016-0328-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s40263-016-0328-5</ArticleId><ArticleId IdType="pmc">PMC4839032</ArticleId><ArticleId IdType="pubmed">27048351</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryerson CJ, Berkeley J, Carrieri-Kohlman VL, Pantilat SZ, Landefeld CS, Collard HR. Depression and functional status are strongly associated with dyspnea in interstitial lung disease. Chest. (2011) 139:609&#x2013;16. 10.1378/chest.10-0608</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.10-0608</ArticleId><ArticleId IdType="pubmed">20688924</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng SKW, Wong CW, Tsang J, Wong KC. Psychological distress and negative appraisals in survivors of severe acute respiratory syndrome (SARS). Psychol Med. (2004) 34:1187&#x2013;95. 10.1017/S0033291704002272</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/S0033291704002272</ArticleId><ArticleId IdType="pubmed">15697045</ArticleId></ArticleIdList></Reference><Reference><Citation>Lam MH-B, Wing Y-K, Yu MW-M, Leung C-M, Ma RCW, Kong APS, et al. . Mental morbidities and chronic fatigue in severe acute respiratory syndrome survivors: long-term follow-up. Arch Intern Med. (2009) 169:2142&#x2013;7. 10.1001/archinternmed.2009.384</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archinternmed.2009.384</ArticleId><ArticleId IdType="pubmed">20008700</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu KK, Chan SK, Ma TM. Posttraumatic stress, anxiety, and depression in survivors of severe acute respiratory syndrome (SARS). J Trauma Stress. (2005) 18:39&#x2013;42. 10.1002/jts.20004</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jts.20004</ArticleId><ArticleId IdType="pmc">PMC7166878</ArticleId><ArticleId IdType="pubmed">16281194</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers JP, Chesney E, Oliver D, Pollak TA, McGuire P, Fusar-Poli P, et al. . Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. (2020) 7:611&#x2013;27. 10.1016/S2215-0366(20)30203-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottemanne H, Delaigue F, Lemogne C. SARS-CoV-2 Psychiatric sequelae: an urgent need of prevention. Front Psychiatry. (2021) 12:1479. 10.3389/fpsyt.2021.738696</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.738696</ArticleId><ArticleId IdType="pmc">PMC8458863</ArticleId><ArticleId IdType="pubmed">34566731</ArticleId></ArticleIdList></Reference><Reference><Citation>Mazza MG, De Lorenzo R, Conte C, Poletti S, Vai B, Bollettini I, et al. . Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors. Brain Behav Immun. (2020) 89:594&#x2013;600. 10.1016/j.bbi.2020.07.037</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.07.037</ArticleId><ArticleId IdType="pmc">PMC7390748</ArticleId><ArticleId IdType="pubmed">32738287</ArticleId></ArticleIdList></Reference><Reference><Citation>Barkow K, Heun R, Ust&#xfc;n TB, Maier W. Identification of items which predict later development of depression in primary health care. Eur Arch Psychiatry Clin Neurosci. (2001) 251:II21&#x2013;6. 10.1007/BF03035122</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF03035122</ArticleId><ArticleId IdType="pubmed">11824830</ArticleId></ArticleIdList></Reference><Reference><Citation>Alhalal EA, Alhalal IA, Alaida AM, Alhweity SM, Alshojaa AY, Alfaori AT. Effects of chronic pain on sleep quality and depression: a cross-sectional study. Saudi Med J. (2021) 42:315&#x2013;23. 10.15537/smj.42.3.20200768</Citation><ArticleIdList><ArticleId IdType="doi">10.15537/smj.42.3.20200768</ArticleId><ArticleId IdType="pmc">PMC7989257</ArticleId><ArticleId IdType="pubmed">33632911</ArticleId></ArticleIdList></Reference><Reference><Citation>Park MJ, Choi KW, Na EJ, Hong JP, Cho MJ, Fava M, et al. . Multiple types of somatic pain increase suicide attempts and depression: a nationwide community sample of Korean adults. Compr Psychiatry. (2019) 90:43&#x2013;8. 10.1016/j.comppsych.2018.12.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.comppsych.2018.12.006</ArticleId><ArticleId IdType="pubmed">30684832</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai X, Hu X, Ekumi IO, Wang J, An Y, Li Z, et al. . Psychological distress and its correlates among COVID-19 Survivors during early convalescence across age groups. Am J Geriatr Psychiatry. (2020) 28:1030&#x2013;9. 10.1016/j.jagp.2020.07.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jagp.2020.07.003</ArticleId><ArticleId IdType="pmc">PMC7347493</ArticleId><ArticleId IdType="pubmed">32753338</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Zheng Y, Shi J, Wang J, Li G, Li C, et al. . Immediate psychological distress in quarantined patients with COVID-19 and its association with peripheral inflammation: a mixed-method study. Brain Behav Immun. (2020) 88:17&#x2013;27. 10.1016/j.bbi.2020.05.038</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbi.2020.05.038</ArticleId><ArticleId IdType="pmc">PMC7235603</ArticleId><ArticleId IdType="pubmed">32416290</ArticleId></ArticleIdList></Reference><Reference><Citation>Grover S, Kumar V, Chakrabarti S, Hollikatti P, Singh P, Tyagi S, et al. . Prevalence and type of functional somatic complaints in patients with first-episode depression. East Asian Arch Psychiatry. (2012) 22(4):146&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23271583</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen HL, Engberg J, Ejlertsen T, Nielsen H. Psychometric scores and persistence of irritable bowel after Campylobacter concisus infection. Scand J Gastroenterol. (2014) 49:545&#x2013;51. 10.3109/00365521.2014.886718</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/00365521.2014.886718</ArticleId><ArticleId IdType="pubmed">24646319</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, Jones K, Dunne J, Mooney A, Gaffney F, et al. . Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. (2020) 15:e0240784. 10.1371/journal.pone.0240784</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Gouraud C, Bottemanne H, Lahlou-Lafor&#xea;t K, Blanchard A, G&#xfc;nther S, Batti SE, et al. . Association between psychological distress, cognitive complaints, and neuropsychological status after a severe COVID-19 episode: a cross-sectional study. Front Psychiatry. (2021) 12:725861. 10.3389/fpsyt.2021.725861</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fpsyt.2021.725861</ArticleId><ArticleId IdType="pmc">PMC8446522</ArticleId><ArticleId IdType="pubmed">34539470</ArticleId></ArticleIdList></Reference><Reference><Citation>Boc&#xe9;r&#xe9;an C, Dupret E. A validation study of the Hospital Anxiety and Depression Scale (HADS) in a large sample of French employees. BMC Psychiatry. (2014) 14:354. 10.1186/s12888-014-0354-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12888-014-0354-0</ArticleId><ArticleId IdType="pmc">PMC4476305</ArticleId><ArticleId IdType="pubmed">25511175</ArticleId></ArticleIdList></Reference><Reference><Citation>Roberts SB, Bonnici DM, Mackinnon AJ, Worcester MC. Psychometric evaluation of the Hospital Anxiety and Depression Scale (HADS) among female cardiac patients. Br J Health Psychol. (2001). 6(Pt 4):373&#x2013;83. 10.1348/135910701169278</Citation><ArticleIdList><ArticleId IdType="doi">10.1348/135910701169278</ArticleId><ArticleId IdType="pubmed">12614511</ArticleId></ArticleIdList></Reference><Reference><Citation>Djukanovic I, Carlsson J, &#xc5;restedt K. Is the Hospital Anxiety and Depression Scale (HADS) a valid measure in a general population 65-80 years old? A psychometric evaluation study. Health Qual Life Outcomes. (2017) 15:193. 10.1186/s12955-017-0759-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12955-017-0759-9</ArticleId><ArticleId IdType="pmc">PMC5628437</ArticleId><ArticleId IdType="pubmed">28978356</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Y, Levis B, Sun Y, He C, Krishnan A, Neupane D, et al. . Accuracy of the Hospital Anxiety and Depression Scale Depression subscale (HADS-D) to screen for major depression: systematic review and individual participant data meta-analysis. BMJ. (2021) 373:n972. 10.1136/bmj.n972</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n972</ArticleId><ArticleId IdType="pmc">PMC8107836</ArticleId><ArticleId IdType="pubmed">33972268</ArticleId></ArticleIdList></Reference><Reference><Citation>Coen SJ, Kano M, Farmer AD, Kumari V, Giampietro V, Brammer M, et al. . Neuroticism influences brain activity during the experience of visceral pain. Gastroenterology. (2011). 141:909.e1&#x2013;17.e1. 10.1053/j.gastro.2011.06.008</Citation><ArticleIdList><ArticleId IdType="doi">10.1053/j.gastro.2011.06.008</ArticleId><ArticleId IdType="pubmed">21699797</ArticleId></ArticleIdList></Reference><Reference><Citation>Kadimpati S, Zale EL, Hooten MW, Ditre JW, Warner DO. Associations between neuroticism and depression in relation to catastrophizing and pain-related anxiety in chronic pain patients. PLoS ONE. (2015) 10:e0126351. 10.1371/journal.pone.0126351</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0126351</ArticleId><ArticleId IdType="pmc">PMC4406532</ArticleId><ArticleId IdType="pubmed">25902153</ArticleId></ArticleIdList></Reference><Reference><Citation>Deary V, Chalder T, Sharpe M. The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev. (2007) 27:781&#x2013;97. 10.1016/j.cpr.2007.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cpr.2007.07.002</ArticleId><ArticleId IdType="pubmed">17822818</ArticleId></ArticleIdList></Reference><Reference><Citation>Toussaint A, Murray AM, Voigt K, Herzog A, Gierk B, Kroenke K, et al. . Development and validation of the somatic symptom disorder-B criteria scale (SSD-12). Psychosom Med. (2016) 78:5&#x2013;12. 10.1097/PSY.0000000000000240</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PSY.0000000000000240</ArticleId><ArticleId IdType="pubmed">26461855</ArticleId></ArticleIdList></Reference><Reference><Citation>Norton S, Cosco T, Doyle F, Done J, Sacker A. The Hospital Anxiety and Depression Scale: a meta confirmatory factor analysis. J Psychosom Res. (2013) 74:74&#x2013;81. 10.1016/j.jpsychores.2012.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jpsychores.2012.10.010</ArticleId><ArticleId IdType="pubmed">23272992</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>